CATALOGO DEI PRODOTTI DELLA RICERCA

PERTILE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.873
EU - Europa 2.854
AS - Asia 1.668
SA - Sud America 229
AF - Africa 71
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.823
RU - Federazione Russa 950
SG - Singapore 668
GB - Regno Unito 538
IT - Italia 532
CN - Cina 476
BR - Brasile 193
DE - Germania 173
FR - Francia 166
HK - Hong Kong 160
VN - Vietnam 134
IE - Irlanda 122
SE - Svezia 119
FI - Finlandia 98
KR - Corea 62
IN - India 31
CA - Canada 27
UA - Ucraina 27
BD - Bangladesh 22
ES - Italia 20
JP - Giappone 19
NL - Olanda 19
BE - Belgio 18
PL - Polonia 18
TR - Turchia 15
ID - Indonesia 13
AU - Australia 11
EC - Ecuador 10
MX - Messico 10
NG - Nigeria 10
SA - Arabia Saudita 10
ZA - Sudafrica 10
TG - Togo 9
AR - Argentina 8
AT - Austria 8
IQ - Iraq 8
PT - Portogallo 8
EG - Egitto 7
PK - Pakistan 7
BJ - Benin 6
CO - Colombia 6
CZ - Repubblica Ceca 6
IR - Iran 6
MA - Marocco 6
TN - Tunisia 6
GR - Grecia 5
NO - Norvegia 5
CL - Cile 4
DO - Repubblica Dominicana 4
JO - Giordania 4
TW - Taiwan 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
IL - Israele 2
JM - Giamaica 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MR - Mauritania 1
MT - Malta 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.706
Salva come PNG Salva come JPEG
Città #
Southend 437
Singapore 363
Ashburn 322
Dallas 318
Moscow 310
Chandler 308
San Jose 300
Woodbridge 198
Ann Arbor 166
Verona 164
Jacksonville 163
Hong Kong 155
Dublin 115
The Dalles 77
Beijing 64
Los Angeles 62
Padova 56
Milan 48
New York 46
Princeton 46
Lawrence 44
Munich 43
Wilmington 41
Houston 39
Ho Chi Minh City 36
Helsinki 35
Nanjing 31
Hanoi 29
Shenyang 28
Tianjin 26
Buffalo 25
Jinan 25
São Paulo 23
Frankfurt am Main 19
Boardman 18
Tokyo 18
Warsaw 18
Orem 17
Zhengzhou 16
Brussels 15
Guangzhou 15
Montreal 15
Santa Clara 15
Columbus 14
Hebei 14
Lancaster 14
Council Bluffs 13
London 13
Sindelfingen 13
Taiyuan 13
Chennai 12
Redondo Beach 12
Haikou 11
Hangzhou 11
Phoenix 11
Seattle 11
Falkenstein 10
Ningbo 10
Rome 10
San Francisco 10
Stockholm 10
Denver 9
Jakarta 9
Jiaxing 9
Lomé 9
Norwalk 9
Redmond 9
Roverbella 9
Taizhou 9
Abuja 8
Atlanta 8
Changsha 8
Chicago 8
Manchester 8
Afragola 7
Ankara 7
Boston 7
Da Nang 7
Dong Ket 7
Haiphong 7
Meda 7
Nanchang 7
Poplar 7
Riyadh 7
Amsterdam 6
Belluno 6
Belo Horizonte 6
Biên Hòa 6
Brooklyn 6
Cotonou 6
Johannesburg 6
Lanzhou 6
Limena 6
Lonigo 6
Melbourne 6
Romola 6
Venice 6
Washington 6
Ballyvaghan 5
Bari 5
Totale 4.797
Salva come PNG Salva come JPEG
Nome #
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 251
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms 246
R&D and market size: who benefits from orphan drug regulation? 223
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 213
Public policies over the life cycle: a large scale OLG model for France, Italy and Sweden 213
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 204
A large scale OLG model for France, Italy and Sweden: assessing the interpersonal and intrapersonal redistributive effects of public policies 202
Investimenti pubblici, risorse scarse: il ruolo dei diversi metodi di supporto alle decisioni 185
Redistribution at the Local Level: The Case of Public Childcare in Italy. University of Verona Department of Economics Working Paper 21/2013 (ISSN 2036-2919) 184
Redistribution at the Local Level: The Case of Public Childcare in Italy 182
DRGs: the link between investment in technologies and appropriateness. WP Series University of Verona Department of Economics (ISSN 2036-2919), 31/2012 177
L'ISEE in Italia: una nota metodologica partendo dai dati EU-SILC. University of Verona Department of Economics Working Paper 6/2014 (ISSN 2036-2919) 175
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 175
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry 165
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients 164
Dynamic, economic approaches to HTA under uncertainty. WP Series University of Verona Department of Economics (ISSN 2036-2919), 03/2011 164
Public finance consolidation and fairness across living generations: the case of Italy. WP Series University of Verona Department of Economics (ISSN 2036-2919), 04/2012 162
Job Sick Leave: Detecting Opportunistic Behavior 162
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 152
Improving access to medicines and promoting pharmaceutical innovation 147
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 147
The dynamics of pharmaceutical regulation and R&D investments. WP Series University of Verona Department of Economics (ISSN 2036-2919), 4/2012 143
Efficienza e sostenibilità dell’intervento pubblico 142
Dynamic, incentive-compatible contracting for health services 142
A reply to "Who would benefit from average value-based pricing?" 141
The timing of adoption of positron emission tomography:a real options approach 139
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography 138
Two-part payments for the reimbursement of investments in health technologies 134
The fiscal disadvantage of young italians: a new view on consolidation and fairness 134
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy 133
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial 133
Investment in health technologies in a competitive model with real options 132
Strategic Interaction in Pharmaceutical Price Regulation: With or Without U? 131
Optimal sequential sampling rules for the economic evaluation of health technologies 131
The dynamics of pharmaceutical regulation and R&D investments 131
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition" 128
Which valued-based price when patients are heterogeneous? 128
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 125
Who should monitor job sick leave? 123
Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies 120
Optimal Decision Rules for HTA Under Uncertainty: a Wider, Dynamic Perspective 120
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 120
Technology adoption, quality and health care costs: a review of the literature 118
Pricing policies when patients are heterogeneous: a welfare analysis 117
The impact of managed entry agreements on pharmaceutical prices 117
R&D and market size: who benefits from orphan drug legislation? 116
Static and dynamic effciency of irreversible health care investments under alternative payment rules 113
L’equità intergenerazionale delle politiche di bilancio 105
Static and Dynamic Efficiency of Irreversible Health Care investments under Alternative Payment Rules 99
Public health interventions: evaluating the economic evaluations 99
Valutare l’efficienza dei servizi ospedalieri in Italia: il caso delle aziende ospedaliero-universitarie 88
Optimal Sequential Sampling with Delayed Observations and Unknown Variance 82
Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition 74
Totale 7.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.943
article - articoli 12.242
book - libri 0
conference - conferenze 384
curatela - curatele 461
other - altro 9.143
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.713
Totale 47.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 13 26 19
2021/2022422 30 70 13 6 19 17 18 25 41 13 66 104
2022/2023804 60 96 72 122 76 194 7 53 84 12 24 4
2023/2024435 18 30 31 72 47 57 27 38 10 16 53 36
2024/20251.183 57 90 67 195 32 32 31 102 162 82 103 230
2025/20263.340 218 177 331 568 833 206 374 183 252 198 0 0
Totale 7.789